Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DPPA2P4 (Developmental pluripotency associated 2 pseudogene 4) is a human pseudogene related to the developmental pluripotency associated 2 (DPPA2) gene family[1][5]. Unlike DPPA2, which encodes a protein involved in early embryonic development and epigenetic regulation, DPPA2P4 does not encode a functional protein. It does not participate in known biological pathways, does not serve as a therapeutic target, and is not implicated in disease or drug interactions. DPPA2P4 should not be confused with DPPA2. DPPA2 is a DNA-binding protein with important roles in regulating zygotic genome activation and stem cell gene networks, but these functions do not apply to DPPA2P4[3][6].
None. Mechanism of action is not applicable to pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Developmental pluripotency associated 2 pseudogene 4 (DPPA2P4).